News & Events

News

All categories

Earnings

Press Release

All years

2020

2019

2018

2017

2016

2015

2014

Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call

March 18, 2015

Affimed to Present at the 27th Annual ROTH Conference

March 3, 2015

Affimed to Present at the BIO CEO & Investor Conference and at the Leerink Partners Global Healthcare Conference

February 3, 2015

Affimed Appoints Dr. Martin Treder as Chief Scientific Officer

January 20, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

January 7, 2015

Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH

December 8, 2014

Affimed Reports Financial Results for Third Quarter 2014

November 18, 2014

Affimed to Present at the Jefferies Global Healthcare Conference – London

November 12, 2014

Affimed Announces Third Quarter 2014 Financial Results Conference Call

November 11, 2014

Affimed Announces Closing of Initial Public Offering

September 17, 2014

Events

All

Scientific

Investors

25Aug

Innate Killer Summit 2020

August 25 - 26, 2020 (virtual)
Presenter: Joachim Koch

09Nov

PEGS Europe

November 9 - 13, 2020 (virtual)
Presenter: Arndt Schottelius

Webcasts
More events